CLNN (Clene Inc.) Sof daromad

CLNN (Clene Inc.) - kompaniyaning tovar belgisi

Neyrodegeneratsiya terapiyasiga bo'lgan talab doimiy bo'lib qolmoqda, bu esa biznesni no-tsiklik qiladi. Operatsion foyda ushbu barqarorlikni aks ettiradi va joriy darajalar -0.04 atrofida shakllangan. Clene Inc. arzon nanokristall dori vositalarini ishlab chiqadi, bu esa yuqori ishlab chiqarish kengayuvchanligini ta'minlaydi. Biroq, keng qamrovli iqtisodiy ustunlik faqatgina kompaniyaning ALSga qarshi maxsus davolash vositalari FDA tomonidan yakuniy tasdiqlanganidan keyin yuzaga keladi.

CLNN: clene.com Sof foyda 04.07.2022 - 29.10.2026

clene.com (CLNN) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Clene|CLNN - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi Clene Inc.|CLNN - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya uchun sof aktivlar Clene|CLNN - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti clene.com|CLNN - Kompaniyaning jami aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning xususiy kapitalga nisbati Clene Inc.|CLNN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Clene|CLNN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Clene Inc.|CLNN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Clene|Shoshilinch likvidlik koeffitsiyenti clene.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
CLNN - Sof foyda
Kompaniyaning jamlanma tahlili:Clene Nanomedicine (CLNN)
Clene Inc. brendining mahsuloti

Tashqi M&A qo'llab-quvvatlashisiz neyro-dorilarni ishlab chiqishga e'tibor qaratgan Clene Inc. (CLNN) uchun operatsion barqarorlik kapitalni boshqarish samaradorligiga kritik darajada bog'liq. Kompaniyaning foydasini tahlil qilish orqali investorlar yashirin kassa oqimi bo'shliqlari va marja sifatini ochib beruvchi kunlik sof daromad tendentsiyalarini kuzatadilar, bu esa sog'liqni saqlash giganti tomonidan strategik sotib olinishdan oldin ushbu biotexnologiya kompaniyasining omon qolish ehtimolini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|Kompaniyaning sof foydasi ACAD (ACADIA Pharma)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Kompaniyaning sof daromadi|SUPN - Kompaniyaning sof foydasi|CPRX (catalystpharma.com) - Kompaniya foydasi|DNLI: Sof foyda|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Sof daromad BHVN|AMLX: Yakuniy foyda|Sof foyda TRVI|Sof moliyaviy natija praxismedicines.com|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|Prothena Biosciences - Sof foyda|Alector, Inc. (ALEC) - Sof daromad|ANNX (Annexon, Inc.) - Sof daromad|OMER - Sof moliyaviy natija|NGNE (Neurogene) - Sof foyda|Sof daromad AC Immune S.A. (ACIU)|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|Kompaniyaning sof foydasi NMRA (Neumora Corp)|Kompaniyaning sof foydasi Scilex Holding Company SCLX|TVGN: Kompaniya foydasi|ACOG - Kompaniyaning sof foydasi|CGTX (cogrx.com) - Kompaniya foydasi|Inhibikase (IKT) - Kompaniyaning sof foydasi|Kompaniya foydasi SAVA|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad VTGN (Vistagen Therapeutics)|Sof foyda ovidrx.com (OVID)|Kompaniyaning sof foydasi Acumen Pharma ABOS|Yakuniy foyda CRVO|ATHE - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi PepGen Inc.|JUNS: Sof foyda|Sof daromad Relmada Therapeutics Inc|Kompaniyaning sof foydasi Annovis Bio Corp|Kompaniyaning sof foydasi GRCE|Sof foyda AIFF|KLTO - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH: Kompaniya foydasi|MetaVia, Inc. - Sof foyda|Kompaniyaning sof daromadi NeurAxis Inc|HSDT (heliusmedical.com) - Sof daromad|Passage Bio - Yakuniy foyda|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Minerva Neurosciences Inc (NERV) - Sof moliyaviy natija|Kompaniyaning sof foydasi Athira (ATHA)|Addex - Kompaniya foydasi|Sof foyda ALZN (Alzamend Neuro)|CYCN - Sof daromad|PTIX: Sof daromad|Sof moliyaviy natija Pasithea Therapeutics KTTA|CRGT: Sof foyda|Sof daromad Avenue Therapeutics Inc|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniyaning sof foydasi CARA|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Kompaniya foydasi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH: Kompaniya foydasi|MRNS - Kompaniyaning sof foydasi|NKGN (nkgenbiotech.com) - Kompaniya foydasi|NRBO: Sof foyda|Kompaniyaning sof daromadi Sage Therapeutics Inc. (SAGE)|Sof daromad SNPX|Sof foyda Trevena Inc|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE